Diverse repertoire of the MHC class II-peptide complexes is required for presentation of viral superantigens

被引:10
作者
Golovkina, TV
Agafonova, Y
Kazansky, D
Chervonsky, A
机构
[1] Jackson Lab, Bar Harbor, ME 04609 USA
[2] Canc Res Ctr, Inst Carcinogensis, Moscow, Russia
关键词
D O I
10.4049/jimmunol.166.4.2244
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Among other features, peptides affect MHC class II molecules, causing changes in the binding of bacterial superantigens (b-Sag), Whether peptides can alter binding of viral superantigens (v-Sag) to MHC class II was not known. Here we addressed the question of whether mutations limiting the diversity of peptides bound by the MHC class II molecules influenced the presentation of v-Sag and, subsequently; the life cycle of the mouse mammary tumor virus (MMTV). T cells reactive to v-Sag were found in mice lacking DM molecules as well as in A(b)Ep-transgenic mice in which MHC class II binding grooves were predominantly occupied by an invariant chain fragment or E alpha (52-68) peptide, respectively, APCs from the mutant mice failed to present v-Sag, as determined by the lack of Sag-specific T cell activation, Sag-induced T cell deletion, and by the aborted MMTV infection. In contrast, mice that express I-A(b) with a variety of hound peptides presented v-Sag and were susceptible to MMTV infection. Comparison of v-Sag and b-Sag presentation by the same mutant cells suggested that presentation of v-Sag had requirements similar to that for presentation of toxic shock syndrome toxin-1. Thus, MHC class II peptide repertoire is critical for recognition of v-Sag by the T cells and affects the outcome of infection with a retrovirus.
引用
收藏
页码:2244 / 2250
页数:7
相关论文
共 58 条
[1]   STRUCTURAL BASIS OF SUPERANTIGEN ACTION INFERRED FROM CRYSTAL-STRUCTURE OF TOXIC-SHOCK SYNDROME TOXIN-1 [J].
ACHARYA, KR ;
PASSALACQUA, EF ;
JONES, EY ;
HARLOS, K ;
STUART, DI ;
BREHM, RD ;
TRANTER, HS .
NATURE, 1994, 367 (6458) :94-97
[2]  
Al-Daccak R, 1998, J IMMUNOL, V160, P225
[3]   B-CELLS ARE ESSENTIAL FOR MURINE MAMMARY-TUMOR VIRUS TRANSMISSION, BUT NOT FOR PRESENTATION OF ENDOGENOUS SUPERANTIGENS [J].
BEUTNER, U ;
KRAUS, E ;
KITAMURA, D ;
RAJEWSKY, K ;
HUBER, BT .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (05) :1457-1466
[4]   Evidence for a conformational change in a class II major histocompatibility complex molecule occurring in the same pH range where antigen binding is enhanced [J].
Boniface, JJ ;
Lyons, DS ;
Wettstein, DA ;
Allbritton, NL ;
Davis, MM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (01) :119-126
[5]  
Buggiano V, 1999, SCAND J IMMUNOL, V49, P269
[6]   Subtle conformational changes induced in major histocompatibility complex class II molecules by binding peptides [J].
Chervonsky, AV ;
Medzhitov, RM ;
Denzin, LK ;
Barlow, AK ;
Rudensky, AY ;
Janeway, CA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (17) :10094-10099
[7]   ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE [J].
CHIRGWIN, JM ;
PRZYBYLA, AE ;
MACDONALD, RJ ;
RUTTER, WJ .
BIOCHEMISTRY, 1979, 18 (24) :5294-5299
[8]   Paracrine transfer of mouse mammary tumor virus superantigen [J].
Delcourt, M ;
Thibodeau, J ;
Denis, F ;
Sekaly, RP .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (03) :471-480
[9]   X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II [J].
Dessen, A ;
Lawrence, CM ;
Cupo, S ;
Zaller, DM ;
Wiley, DC .
IMMUNITY, 1997, 7 (04) :473-481
[10]   CHARACTERIZATION OF THE MURINE ANTIGENIC DETERMINANT, DESIGNATED L3T4A, RECOGNIZED BY MONOCLONAL-ANTIBODY GK1.5 - EXPRESSION OF L3T4A BY FUNCTIONAL T-CELL CLONES APPEARS TO CORRELATE PRIMARILY WITH CLASS II MHC ANTIGEN-REACTIVITY [J].
DIALYNAS, DP ;
WILDE, DB ;
MARRACK, P ;
PIERRES, A ;
WALL, KA ;
HAVRAN, W ;
OTTEN, G ;
LOKEN, MR ;
PIERRES, M ;
KAPPLER, J ;
FITCH, FW .
IMMUNOLOGICAL REVIEWS, 1983, 74 :29-56